Troponin I
Alternative Names: Cartilage-derived inhibitor; CDILatest Information Update: 15 Oct 2021
Price :
$50 *
At a glance
- Originator Childrens Hospital Boston
- Class Contractile proteins; Eye disorder therapies; Microfilament proteins; Muscle proteins; Troponin
- Mechanism of Action Angiogenesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer metastases; Eye disorders; Macular degeneration; Solid tumours
Most Recent Events
- 09 Aug 2007 Discontinued - Preclinical for Cancer metastases in USA (unspecified route)
- 09 Aug 2007 Discontinued - Preclinical for Eye disorders in USA (Ophthalmic)
- 09 Aug 2007 Discontinued - Preclinical for Macular degeneration in USA (unspecified route)